Effect of gadolinium-based nanoparticles on nuclear DNA damage and repair in glioblastoma tumor cells

. 2016 Jul 28 ; 14 (1) : 63. [epub] 20160728

Jazyk angličtina Země Anglie, Velká Británie Médium electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid27464501
Odkazy

PubMed 27464501
PubMed Central PMC4964094
DOI 10.1186/s12951-016-0215-8
PII: 10.1186/s12951-016-0215-8
Knihovny.cz E-zdroje

BACKGROUND: Tumor targeting of radiotherapy represents a great challenge. The addition of multimodal nanoparticles, such as 3 nm gadolinium-based nanoparticles (GdBNs), has been proposed as a promising strategy to amplify the effects of radiation in tumors and improve diagnostics using the same agents. This singular property named theranostic is a unique advantage of GdBNs. It has been established that the amplification of radiation effects by GdBNs appears due to fast electronic processes. However, the influence of these nanoparticles on cells is not yet understood. In particular, it remains dubious how nanoparticles activated by ionizing radiation interact with cells and their constituents. A crucial question remains open of whether damage to the nucleus is necessary for the radiosensitization exerted by GdBNs (and other nanoparticles). METHODS: We studied the effect of GdBNs on the induction and repair of DNA double-strand breaks (DSBs) in the nuclear DNA of U87 tumor cells irradiated with γ-rays. For this purpose, we used currently the most sensitive method of DSBs detection based on high-resolution confocal fluorescence microscopy coupled with immunodetection of two independent DSBs markers. RESULTS: We show that, in the conditions where GdBNs amplify radiation effects, they remain localized in the cytoplasm, i.e. do not penetrate into the nucleus. In addition, the presence of GdBNs in the cytoplasm neither increases induction of DSBs by γ-rays in the nuclear DNA nor affects their consequent repair. CONCLUSIONS: Our results suggest that the radiosensitization mediated by GdBNs is a cytoplasmic event that is independent of the nuclear DNA breakage, a phenomenon commonly accepted as the explanation of biological radiation effects. Considering our earlier recognized colocalization of GdBNs with the lysosomes and endosomes, we revolutionary hypothesize here about these organelles as potential targets for (some) nanoparticles. If confirmed, this finding of cytoplasmically determined radiosensitization opens new perspectives of using nano-radioenhancers to improve radiotherapy without escalating the risk of pathologies related to genetic damage.

Zobrazit více v PubMed

Hainfeld JF, Slatkin DN, Smilowitz HM. The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol. 2004;49:N309–N315. doi: 10.1088/0031-9155/49/18/N03. PubMed DOI

Jain S, Coulter JA, Hounsell AR, Butterworth KT, McMahon SJ, Hyland WB, et al. Cell-specific radiosensitization by gold nanoparticles at megavoltage radiation energies. Int J Radiat Oncol Biol Phys. 2011;79:531–539. doi: 10.1016/j.ijrobp.2010.08.044. PubMed DOI PMC

Chithrani DB, Jelveh S, Jalali F, van Prooijen M, Allen C, Bristow RG, et al. Gold nanoparticles as radiation sensitizers in cancer therapy. Radiat Res. 2010;173:719–728. doi: 10.1667/RR1984.1. PubMed DOI

Hainfeld JF, Dilmanian FA, Slatkin DN, Smilowitz HM. Radiotherapy enhancement with gold nanoparticles. J Pharm Pharmacol. 2008;60:977–985. doi: 10.1211/jpp.60.8.0005. PubMed DOI

Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986;46:6387–6392. PubMed

Noguchi Y, Wu J, Duncan R, Strohalm J, Ulbrich K, Akaike T, et al. Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues. Jpn J Cancer Res. 1998;89:307–314. doi: 10.1111/j.1349-7006.1998.tb00563.x. PubMed DOI PMC

Powell AC, Paciotti GF, Libutti SK. Colloidal gold: a novel nanoparticle for targeted cancer therapeutics. Methods Mol Biol. 2010;624:375–384. doi: 10.1007/978-1-60761-609-2_25. PubMed DOI

Lim Z-ZJ, Li J-EJ, Ng C-T, Yung L-YL, Bay B-H. Gold nanoparticles in cancer therapy. Acta Pharmacol Sin. 2011;32:983–990. doi: 10.1038/aps.2011.82. PubMed DOI PMC

Hainfeld JF, Slatkin DN, Focella TM, Smilowitz HM. Gold nanoparticles: a new X-ray contrast agent. Br J Radiol. 2006;79:248–253. doi: 10.1259/bjr/13169882. PubMed DOI

Chattopadhyay N, Cai Z, Kwon YL, Lechtman E, Pignol J-P, Reilly RM. Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiation. Breast Cancer Res Treat. 2013;137:81–91. doi: 10.1007/s10549-012-2338-4. PubMed DOI

Mieszawska AJ, Mulder WJM, Fayad ZA, Cormode DP. Multifunctional gold nanoparticles for diagnosis and therapy of disease. Mol Pharm. 2013;10:831–847. doi: 10.1021/mp3005885. PubMed DOI PMC

Chang M-Y, Shiau A-L, Chen Y-H, Chang C-J, Chen HH-W, Wu C-L. Increased apoptotic potential and dose-enhancing effect of gold nanoparticles in combination with single-dose clinical electron beams on tumor-bearing mice. Cancer Sci. 2008;99:1479–1484. doi: 10.1111/j.1349-7006.2008.00827.x. PubMed DOI PMC

Zhang X, Xing JZ, Chen J, Ko L, Amanie J, Gulavita S, et al. Enhanced radiation sensitivity in prostate cancer by gold-nanoparticles. Clin Investig Med Médecine Clin Exp. 2008;31:E160–E167. PubMed

Zheng Y, Hunting DJ, Ayotte P, Sanche L. Radiosensitization of DNA by gold nanoparticles irradiated with high-energy electrons. Radiat Res. 2008;169:19–27. doi: 10.1667/RR1080.1. PubMed DOI

Porcel E, Kobayashi K, Usami N, Remita H, Le Sech C, Lacombe S. Photosensitization of plasmid-DNA loaded with platinum nano-particles and irradiated by low energy X-rays. J Phys Conf Ser. 2011;261:12004. doi: 10.1088/1742-6596/261/1/012004. DOI

Porcel E, Li S, Usami N, Remita H, Furusawa Y, Kobayashi K, et al. Nano-Sensitization under gamma rays and fast ion radiation. J Phys Conf Ser. 2012;373:12006. doi: 10.1088/1742-6596/373/1/012006. DOI

Maier-Hauff K, Ulrich F, Nestler D, Niehoff H, Wust P, Thiesen B, et al. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J Neurooncol. 2011;103:317–324. doi: 10.1007/s11060-010-0389-0. PubMed DOI PMC

Bradbury MS, Phillips E, Montero PH, Cheal SM, Stambuk H, Durack JC, et al. Clinically-translated silica nanoparticles as dual-modality cancer-targeted probes for image-guided surgery and interventions. Integr Biol. 2013;5:74–86. doi: 10.1039/C2IB20174G. PubMed DOI PMC

Sharma P, Brown SC, Walter G, Santra S, Scott E, Ichikawa H, et al. Gd nanoparticulates: from magnetic resonance imaging to neutron capture therapy. Adv Powder Technol. 2007;18:663–698. doi: 10.1163/156855207782515030. DOI

Tillement O, Roux S, Perriat P, Leduc G, Mandon C, Mutelet B, et al. Utilisation de nanoparticules a base de lanthanides comme agents radiosensibilisants; 2008. http://www.google.com/patents/EP2200659A2?cl=fr. Accessed 23 Jul 2015.

Le Duc G, Miladi I, Alric C, Mowat P, Bräuer-Krisch E, Bouchet A, et al. Toward an image-guided microbeam radiation therapy using gadolinium-based nanoparticles. ACS Nano. 2011;5:9566–9574. doi: 10.1021/nn202797h. PubMed DOI

Mowat P, Mignot A, Rima W, Lux F, Tillement O, Roulin C, et al. In vitro radiosensitizing effects of ultrasmall gadolinium based particles on tumour cells. J Nanosci Nanotechnol. 2011;11:7833–7839. doi: 10.1166/jnn.2011.4725. PubMed DOI

Porcel E, Tillement O, Lux F, Mowat P, Usami N, Kobayashi K, et al. Gadolinium-based nanoparticles to improve the hadrontherapy performances. Nanomed Nanotechnol Biol Med. 2014;10:1601–1608. doi: 10.1016/j.nano.2014.05.005. PubMed DOI

Sancey L, Lux F, Kotb S, Roux S, Dufort S, Bianchi A, et al. The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy. Br J Radiol. 2014;87:20140134. doi: 10.1259/bjr.20140134. PubMed DOI PMC

Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO Classification of Tumours of the Central Nervous System. Acta Neuropathol (Berl.) 2007;2007(114):97–109. doi: 10.1007/s00401-007-0243-4. PubMed DOI PMC

Bridot J-L, Faure A-C, Laurent S, Rivière C, Billotey C, Hiba B, et al. Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging. J Am Chem Soc. 2007;129:5076–5084. doi: 10.1021/ja068356j. PubMed DOI

Mignot A, Truillet C, Lux F, Sancey L, Louis C, Denat F, et al. A top-down synthesis route to ultrasmall multifunctional Gd-based Silica nanoparticles for theranostic applications. Chem Eur J. 2013;19:6122–6136. doi: 10.1002/chem.201203003. PubMed DOI

Lux F, Mignot A, Mowat P, Louis C, Dufort S, Bernhard C, et al. Ultrasmall rigid particles as multimodal probes for medical applications. Angew Chem Int Ed. 2011;50:12299–12303. doi: 10.1002/anie.201104104. PubMed DOI

Roux S, Tillement O, Billotey C, Coll JL, Duc GL, Marquette CA, et al. Multifunctional nanoparticles: from the detection of biomolecules to the therapy. Int J Nanotechnol. 2010;7:781. doi: 10.1504/IJNT.2010.031744. DOI

Bianchi A, Dufort S, Lux F, Courtois A, Tillement O, Coll J-L, et al. Quantitative biodistribution and pharmacokinetics of multimodal gadolinium-based nanoparticles for lungs using ultrashort TE MRI. Magn Reson Mater Phys Biol Med. 2014;27:303–316. doi: 10.1007/s10334-013-0412-5. PubMed DOI

Štefančíková L, Porcel E, Eustache P, Li S, Salado D, Marco S, et al. Cell localisation of gadolinium-based nanoparticles and related radiosensitising efficacy in glioblastoma cells. Cancer Nanotechnol. 2014;5:1–15. doi: 10.1186/s12645-014-0001-y. PubMed DOI PMC

Rima W, Sancey L, Aloy M-T, Armandy E, Alcantara GB, Epicier T, et al. Internalization pathways into cancer cells of gadolinium-based radiosensitizing nanoparticles. Biomaterials. 2013;34:181–195. doi: 10.1016/j.biomaterials.2012.09.029. PubMed DOI

Miladi I, Aloy M-T, Armandy E, Mowat P, Kryza D, Magné N, et al. Combining ultrasmall gadolinium-based nanoparticles with photon irradiation overcomes radioresistance of head and neck squamous cell carcinoma. Nanomed Nanotechnol Biol Med. 2015;11:247–257. doi: 10.1016/j.nano.2014.06.013. PubMed DOI

Butterworth KT, McMahon SJ, Taggart LE, Prise KM. Radiosensitization by gold nanoparticles: effective at megavoltage energies and potential role of oxidative stress. Transl Cancer Res. 2013;2:269–279.

Misawa M, Takahashi J. Generation of reactive oxygen species induced by gold nanoparticles under x-ray and UV Irradiations. Nanomed Nanotechnol Biol Med. 2011;7:604–614. doi: 10.1016/j.nano.2011.01.014. PubMed DOI

Porcel E, Liehn S, Remita H, Usami N, Kobayashi K, Furusawa Y, et al. Platinum nanoparticles: a promising material for future cancer therapy? Nanotechnology. 2010;21:85103. doi: 10.1088/0957-4484/21/8/085103. PubMed DOI

Krpetić Ž, Nativo P, Sée V, Prior IA, Brust M, Volk M. Inflicting controlled nonthermal damage to subcellular structures by laser-activated gold nanoparticles. Nano Lett. 2010;10:4549–4554. doi: 10.1021/nl103142t. PubMed DOI

McMahon SJ, Hyland WB, Muir MF, Coulter JA, Jain S, Butterworth KT, et al. Nanodosimetric effects of gold nanoparticles in megavoltage radiation therapy. Radiother Oncol. 2011;100:412–416. doi: 10.1016/j.radonc.2011.08.026. PubMed DOI

McMahon SJ, Hyland WB, Muir MF, Coulter JA, Jain S, Butterworth KT, et al. Biological consequences of nanoscale energy deposition near irradiated heavy atom nanoparticles. Sci Rep. 2011;1. http://www.nature.com/srep/2011/110620/srep00018/full/srep00018.html. Accessed 22 Jul 2015. PubMed PMC

Lechtman E, Mashouf S, Chattopadhyay N, Keller BM, Lai P, Cai Z, et al. A Monte Carlo-based model of gold nanoparticle radiosensitization accounting for increased radiobiological effectiveness. Phys Med Biol. 2013;58:3075–3087. doi: 10.1088/0031-9155/58/10/3075. PubMed DOI

Burger N, Biswas A, Barzan D, Kirchner A, Hosser H, Hausmann M, et al. A method for the efficient cellular uptake and retention of small modified gold nanoparticles for the radiosensitization of cells. Nanomed Nanotechnol Biol Med. 2014;10:1365–1373. doi: 10.1016/j.nano.2014.03.011. PubMed DOI

Kassis AI, Adelstein SJ. Radiobiologic principles in radionuclide therapy. J Nucl Med Off. Publ Soc Nucl Med. 2005;46(Suppl 1):4S–12S. PubMed

Belli M, Sapora O, Tabocchini MA. Molecular targets in cellular response to ionizing radiation and implications in space radiation protection. J Radiat Res. 2002;43(Suppl):S13–S19. doi: 10.1269/jrr.43.S13. PubMed DOI

Usami N, Furusawa Y, Kobayashi K, Lacombe S, Reynaud-Angelin A, Sage E, et al. Mammalian cells loaded with platinum-containing molecules are sensitized to fast atomic ions. Int J Radiat Biol. 2008;84:603–611. doi: 10.1080/09553000802199846. PubMed DOI

Kong T, Zeng J, Wang X, Yang X, Yang J, McQuarrie S, et al. Enhancement of radiation cytotoxicity in breast-cancer cells by localized attachment of gold nanoparticles. Small. 2008;4:1537–1543. doi: 10.1002/smll.200700794. PubMed DOI

Jones BL, Krishnan S, Cho SH. Estimation of microscopic dose enhancement factor around gold nanoparticles by Monte Carlo calculations. Med Phys. 2010;37:3809. doi: 10.1118/1.3455703. PubMed DOI

Leung MKK, Chow JCL, Chithrani BD, Lee MJG, Oms B, Jaffray DA. Irradiation of gold nanoparticles by X-rays: Monte Carlo simulation of dose enhancements and the spatial properties of the secondary electrons production. Med Phys. 2011;38:624–631. doi: 10.1118/1.3539623. PubMed DOI

Tartier L, Gilchrist S, Burdak-Rothkamm S, Folkard M, Prise KM. Cytoplasmic irradiation induces mitochondrial-dependent 53BP1 protein relocalization in irradiated and bystander cells. Cancer Res. 2007;67:5872–5879. doi: 10.1158/0008-5472.CAN-07-0188. PubMed DOI PMC

Wu L-J, Randers-Pehrson G, Xu A, Waldren CA, Geard CR, Yu Z, et al. Targeted cytoplasmic irradiation with alpha particles induces mutations in mammalian cells. Proc Natl Acad Sci. 1999;96:4959–4964. doi: 10.1073/pnas.96.9.4959. PubMed DOI PMC

Morlieras J, Chezal J-M, Miot-Noirault E, Roux A, Heinrich-Balard L, Cohen R, et al. Development of gadolinium based nanoparticles having an affinity towards melanin. Nanoscale. 2013;5:1603–1615. doi: 10.1039/c2nr33457g. PubMed DOI

Falk M, Lukasova E, Gabrielova B, Ondrej V, Kozubek S. Chromatin dynamics during DSB repair. Biochim Biophys Acta. 2007;1773:1534–1545. doi: 10.1016/j.bbamcr.2007.07.002. PubMed DOI

Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem. 1998;273:5858–5868. doi: 10.1074/jbc.273.10.5858. PubMed DOI

Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature. 2003;421:499–506. doi: 10.1038/nature01368. PubMed DOI

Kozubek M, Kozubek S, Lukásová E, Marecková A, Bártová E, Skalníková M, et al. High-resolution cytometry of FISH dots in interphase cell nuclei. Cytometry. 1999;36:279–293. doi: 10.1002/(SICI)1097-0320(19990801)36:4<279::AID-CYTO2>3.0.CO;2-G. PubMed DOI

Kozubek M, Kozubek S, Lukásová E, Bártová E, Skalníková M, Matula P, et al. Combined confocal and wide-field high-resolution cytometry of fluorescent in situ hybridization-stained cells. Cytometry. 2001;45:1–12. doi: 10.1002/1097-0320(20010901)45:1<1::AID-CYTO1138>3.0.CO;2-M. PubMed DOI

Matula P, Maska M, Danek O, Matula P, Kozubek M. Acquiarium: free software for the acquisition and analysis of 3D images of cells in fluorescence microscopy. In: IEEE International Symposium on Biomedical Imaging: from Nano to Macro 2009 ISBI 09; 2009. p. 1138–41.

Kim S, Choi JE, Choi J, Chung K-H, Park K, Yi J, et al. Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol In Vitro. 2009;23:1076–1084. doi: 10.1016/j.tiv.2009.06.001. PubMed DOI

Ahamed M, Karns M, Goodson M, Rowe J, Hussain SM, Schlager JJ, et al. DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells. Toxicol Appl Pharmacol. 2008;233:404–410. doi: 10.1016/j.taap.2008.09.015. PubMed DOI

Zheng Q, Yang H, Wei J, Tong J, Shu Y. The role and mechanisms of nanoparticles to enhance radiosensitivity in hepatocellular cell. Biomed Pharmacother. 2013;67:569–575. doi: 10.1016/j.biopha.2013.04.003. PubMed DOI

Kang B, Mackey MA, El-Sayed MA. Nuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosis. J Am Chem Soc. 2010;132:1517–1519. doi: 10.1021/ja9102698. PubMed DOI

Li JJ, Zou L, Hartono D, Ong C-N, Bay B-H, Lanry Yung L-Y. Gold nanoparticles induce oxidative damage in lung fibroblasts in vitro. Adv Mater. 2008;20:138–142. doi: 10.1002/adma.200701853. DOI

Trono JD, Mizuno K, Yusa N, Matsukawa T, Yokoyama K, Uesaka M. Size, concentration and incubation time dependence of gold nanoparticle uptake into pancreas cancer cells and its future application to X-ray drug delivery system. J Radiat Res. 2011;52:103–109. doi: 10.1269/jrr.10068. PubMed DOI

Prise KM, Folkard M, Kuosaite V, Tartier L, Zyuzikov N, Shao C. What role for DNA damage and repair in the bystander response? Mutat Res (Tokyo) 2006;597:1–4. doi: 10.1016/j.mrfmmm.2005.06.034. PubMed DOI

Zhou H, Hong M, Chai Y, Hei TK. Consequences of cytoplasmic irradiation: studies from microbeam. J Radiat Res (Tokyo) 2009;50(Suppl A):A59–A65. doi: 10.1269/jrr.08120S. PubMed DOI PMC

Morgan WF. Non-targeted and delayed effects of exposure to ionizing radiation: I. Radiation-induced genomic instability and bystander effects in vitro. Radiat Res. 2003;159:567–580. doi: 10.1667/0033-7587(2003)159[0567:NADEOE]2.0.CO;2. PubMed DOI

Morgan WF. Non-targeted and delayed effects of exposure to ionizing radiation: II. Radiation-induced genomic instability and bystander effects in vivo, clastogenic factors and transgenerational effects. Radiat Res. 2003;159:581–596. doi: 10.1667/0033-7587(2003)159[0581:NADEOE]2.0.CO;2. PubMed DOI

Mothersill C, Seymour CB. Radiation-induced bystander effects—implications for cancer. Nat Rev Cancer. 2004;4:158–164. doi: 10.1038/nrc1277. PubMed DOI

Prise KM, Schettino G, Folkard M, Held KD. New insights on cell death from radiation exposure. Lancet Oncol. 2005;6:520–528. doi: 10.1016/S1470-2045(05)70246-1. PubMed DOI

Cuervo AM, Dice JF. Lysosomes, a meeting point of proteins, chaperones, and proteases. J Mol Med. 1998;76:6–12. doi: 10.1007/s109-1998-8099-y. PubMed DOI

Eskelinen E-L, Tanaka Y, Saftig P. At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol. 2003;13:137–145. doi: 10.1016/S0962-8924(03)00005-9. PubMed DOI

Luzio JP, Pryor PR, Bright NA. Lysosomes: fusion and function. Nat Rev Mol Cell Biol. 2007;8:622–632. doi: 10.1038/nrm2217. PubMed DOI

Turk B, Turk V. Lysosomes as “suicide bags” in cell death: myth or reality? J Biol Chem. 2009;284:21783–21787. doi: 10.1074/jbc.R109.023820. PubMed DOI PMC

Boya P, Kroemer G. Lysosomal membrane permeabilization in cell death. Oncogene. 2008;27:6434–6451. doi: 10.1038/onc.2008.310. PubMed DOI

Settembre C, Fraldi A, Medina DL, Ballabio A. Signals for the lysosome: a control center for cellular clearance and energy metabolism. Nat Rev Mol Cell Biol. 2013;14:283–296. doi: 10.1038/nrm3565. PubMed DOI PMC

Kurz T, Terman A, Gustafsson B, Brunk UT. Lysosomes in iron metabolism, ageing and apoptosis. Histochem Cell Biol. 2008;129:389–406. doi: 10.1007/s00418-008-0394-y. PubMed DOI PMC

Heid ME, Keyel PA, Kamga C, Shiva S, Watkins SC, Salter RD. Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation. J Immunol. 2013;191:5230–5238. doi: 10.4049/jimmunol.1301490. PubMed DOI PMC

Moser F, Hildenbrand G, Müller P, Al Saroori A, Biswas A, Bach M, et al. Cellular uptake of gold nanoparticles and their behavior as labels for localization microscopy. Biophys J. 2016;110:947–953. doi: 10.1016/j.bpj.2016.01.004. PubMed DOI PMC

Berbeco RI, Korideck H, Ngwa W, Kumar R, Patel J, Sridhar S, et al. DNA damage enhancement from gold nanoparticles for clinical MV photon beams. Radiat Res. 2012;178:604–608. doi: 10.1667/RR3001.1. PubMed DOI PMC

Zhu C, Zheng Q, Wang L, Xu H-F, Tong J, Zhang Q, et al. Synthesis of novel galactose functionalized gold nanoparticles and its radiosensitizing mechanism. J Nanobiotechnol. 2015;13. http://www.jnanobiotechnology.com/content/13/1/67. Accessed 30 Mar 2016. PubMed PMC

Mukherjee B, Kessinger C, Kobayashi J, Chen BPC, Chen DJ, Chatterjee A, et al. DNA-PK phosphorylates histone H2AX during apoptotic DNA fragmentation in mammalian cells. DNA Repair. 2006;5:575–590. doi: 10.1016/j.dnarep.2006.01.011. PubMed DOI

Marti TM, Hefner E, Feeney L, Natale V, Cleaver JE. H2AX phosphorylation within the G1 phase after UV irradiation depends on nucleotide excision repair and not DNA double-strand breaks. Proc Natl Acad Sci USA. 2006;103:9891–9896. doi: 10.1073/pnas.0603779103. PubMed DOI PMC

Hofer M, Falk M, Komůrková D, Falková I, Bačíková A, Klejdus B, et al. Two new faces of amifostine: protector from DNA damage in normal cells and inhibitor of DNA repair in cancer cells. J Med Chem. 2016;59:3003–3017. doi: 10.1021/acs.jmedchem.5b01628. PubMed DOI

Falk M, Lukasova E, Falkova I, Stefancikova L, Jezkova L, Bacikova A, et al. Chromatin differentiation of white blood cells decreases DSB damage induction, prevents functional assembly of repair foci, but has no influence on protrusion of heterochromatic DSBs into the low-dense chromatin. J Radiat Res (Tokyo) 2014;55:i81–i82. doi: 10.1093/jrr/rrt194. DOI

Ježková L, Falk M, Falková I, Davídková M, Bačíková A, Štefančíková L, et al. Function of chromatin structure and dynamics in DNA damage, repair and misrepair: γ-rays and protons in action. Appl Radiat Isot. 2014;83:128–136. doi: 10.1016/j.apradiso.2013.01.022. PubMed DOI

de Feraudy S, Revet I, Bezrookove V, Feeney L, Cleaver JE. A minority of foci or pan-nuclear apoptotic staining of γH2AX in the S phase after UV damage contain DNA double-strand breaks. Proc Natl Acad Sci USA. 2010;107:6870–6875. doi: 10.1073/pnas.1002175107. PubMed DOI PMC

Wakasugi M, Sasaki T, Matsumoto M, Nagaoka M, Inoue K, Inobe M, et al. Nucleotide Excision Repair-dependent DNA Double-strand Break Formation and ATM Signaling Activation in Mammalian Quiescent Cells. J Biol Chem. 2014 PubMed PMC

Falk M. Nanoscopy and nanoparticles hand-in-hand to fight cancer: an exciting entrée into the rising NANOworld. Biophys J. 2016;110:872–873. doi: 10.1016/j.bpj.2016.01.005. PubMed DOI PMC

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...